Medicinal Organic Cannabis Australia (MOCA) has a clear business strategy to become a leading national and international producer, wholesaler and retailer of cannabis-based products. The Company is focused on rapidly expanding to meet the expected demand in the Australian medicinal cannabis market, as well as expanding internationally to cater to the global demand for medical cannabis products.
To achieve this, MOCA is building a range of wholesale MOCA branded cannabis-based products in Australia. The Company is working with the 'best in field' for logistics and distribution of its medical cannabis products, ensuring efficient and reliable delivery to customers. MOCA is also working closely with wholesale clients, including hospitals, medical practitioners and cannabis clinics in Australia, to expand its customer base.
In addition, MOCA is expanding its healthcare client base in Australia and internationally through digital promotions and practitioner partnerships. The Company is leveraging its cultivation and production process to constantly improve its quality and pricing, while supporting its online and offline distribution network.
MOCA's growth strategy is underpinned by its innovative MOCA Health cannabis clinic, which provides the Company with direct access to consumers of its organic medical products. Over the next one to three years, MOCA will continue to grow the business through the manufacture of organic products and development of the MOCA brand. The Company is focused on engaging new patients and working with its patient base to deliver outstanding patient services.
To achieve its growth targets, MOCA will operate on a staged approach, leveraging its licences to bring a variety of federally approved medical cannabis products into its secure pharmaceutical facility in New South Wales. The Company's import licence enables it to wholesale its cannabis products to pharmacies, hospitals and licensed medical professionals, while its export licence enables the Company to sell products to licensed buyers around the world.
As part of its expansion strategy, MOCA is also focused on expanding its cultivation base in Europe exponentially to cater to international demand. The Company's commitment to expanding its operations internationally, while maintaining its focus on providing high-quality organic medication, makes it an attractive option for investors looking to enter the growing industry of medicinal cannabis.